Firms & Funds Drug backer Sofinnova rounds up $500 mln for Fund IX Chris Witkowsky - 23 July 2014 Share A- A+ 100% Create an account to continue reading Gain instant access to our expert editorial analysis and in-depth insight. Register for free Already have an account? Sign in
